Archived Insight | March 16, 2023

The End of COVID-19 Emergencies

On January 30, 2023, the Biden Administration announced it would end both the public health emergency (PHE) and national emergency (NE) related to COVID-19 effective May 11, 2023. As healthcare costs related to COVID-19 begin to transition, plan sponsors will need to make decisions whether to continue to allow coverage and flexibility under the PHE and NE rules, go back to pre-COVID-19 rules or compromise somewhere in the middle.

End of COVID-19 Emergencies and the Impact to Plan Sponsors and Participants

In this webinar...

Our experts discussed the considerations for plan sponsors and provided data and additional details to help determine the best path forward, including:

  • The emergency ending and what that transition means for health plans
  • COVID-19 costs and the transition impact to plan sponsors and participants
  • Communication requirements and best practices to keep participants informed

Webinar Replay

 

Speakers

Kathryn Bakich, Senior Vice President, Health Compliance Practice Leader
Jason Jossie, Senior Health Consultant
Angela Purdum, Vice President, Communications

Get the Slides

Don’t have time to watch a video right now? No worries. Here is a copy of the slides from this session.

Download Now

See more insights

Multi Generation And Ethnic Group Of Colleagues At Meeting

Personal and Well-Timed Benefits Communications Are Powerful

Personalized benefits messaging — tailored to individual needs — increases employee engagement. Get the three steps to making communications personal.
Mature Woman At Home Getting Packages And Letters In The Mail

HIPAA Privacy Notice Updates to Consider

Information about enhanced privacy protections for reproductive healthcare should be removed from HIPAA-mandated Notice of Privacy Practices.
Nurses Taking Patient To An Emergency Room

Some 2026 Projected Health Plan Cost Trends at 10-Year Highs

Segal’s 2026 Health Plan Cost Trend Survey findings help plan sponsors anticipate and manage soaring medical and prescription drug healthcare costs.

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.